CPhI survey: pharma leaders optimistic about the future : co

CPhI survey: pharma leaders optimistic about the future


CPhI survey: pharma leaders optimistic about the future
According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth.
CPhI has released a survey taking the post-pandemic temperature pharmaceutical leaders, gauging how they feel about the industry’s prospects in the immediate and medium-term future. The findings in the report (to be outlined in a May 20 session during the organization’s virtual CPhI Discover event) reveal companies and governmental bodies alike are keenly interested in increasing regional self-reliance, reducing system complexity, and more.
Outsourcing-Pharma spoke about the survey, and notable CPhI Discover sessions worth a closer look, with Tara Dougal, head of content at Informa Markets.

Related Keywords

China , Eric Langer , Kevin Sharp , Samsung Biologics , Vicky Xia , Peter Shapiro , Tara Dougal , Bioplan Associates , Global Data Company , Drug Delivery Start Ups , Drug Delivery , Pharma Ingredients , Bioplan Associate Vicky Xia , Mindful Working , Markets Amp Regulations , Clinical Development , Contract Manufacturing Amp Logistics , Covid 19 , Processing Equipment , Contract Manufacturing , Contract Sales Amp Marketing , Supply Chain , Logistics , Market , Cphi Worldwide , Manufacturing , Investment , சீனா , எரிக் லாங்கர் , கெவின் கூர்மையான , சாம்சங் உயிரியல் , விக்கி கிஷிய , பீட்டர் ஷாபிரோ , தாரா டூகல் , உலகளாவிய தகவல்கள் நிறுவனம் , மருந்து டெலிவரி , பார்மா பொருட்கள் , சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள் , விட் ,

© 2025 Vimarsana